Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longboard Pharmaceuticals Inc
(NQ:
LBPH
)
31.20
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Longboard Pharmaceuticals Inc
< Previous
1
2
Next >
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
November 02, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November
November 01, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023
October 05, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023
September 19, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Participate in Three Upcoming Investor Conferences
August 31, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings
August 30, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathies
August 23, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Upcoming Investor Conferences
August 03, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023
June 26, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 09, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives
March 02, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023
February 23, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
February 10, 2023
From
Longboard Pharmaceuticals
Via
Business Wire
Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock
February 07, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
February 07, 2023
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Announces Positive Topline Data from a Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics and Pharmacodynamics of LP352 in Healthy Volunteers
December 05, 2022
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community
November 29, 2022
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Present at Guggenheim’s Healthcare Talks 4th Annual Immunology and Neurology Day
November 08, 2022
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Longboard Pharmaceuticals, Inc.
Via
Business Wire
Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
September 29, 2022
From
Longboard Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.